Fig. 3
From: China antimicrobial resistance surveillance network for pets (CARPet), 2018 to 2021
Heatmaps showing the susceptibility of pet-derived Enterobacterales isolates including E. coli, Klebsiella spp., Enterobacter spp., and Proteus spp. to antimicrobial agents. Abbreviations: ampicillin (AMP), amoxicillin-clavulanate (AMC), ceftriaxone (CRO), cefquinome (CEQ), meropenem (MEM), doxycycline (DOX), tigecycline (TGC), gentamicin (GEN), amikacin (AMK), colistin (COL), florfenicol (FFC), levofloxacin (LVX), enrofloxacin (ENR), trimethoprim-sulfamethoxazole (SXT). The short black horizontal line in grey cells indicates that bacteria of the respective species are intrinsically resistant to the corresponding antimicrobial agents. The statistical differences in resistance rates to the corresponding antimicrobial agents between canine and feline isolates are indicated by asterisks. p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***) are considered as statistically significant. For ampicillin and amoxicillin-clavulanate, only the susceptibility of isolates from urinary tract samples is reported, with the number of E. coli, Klebsiella spp. and Proteus spp. being 462, 79, and 131 in total, 316, 61 and 126 in dogs, and 146, 18 and 5 in cats, respectively. For the remaining antimicrobial agents, the number (n) of all isolates is indicated in the figure